Tilray Brands, Inc.

TLRY.TO·Toronto·Healthcare
Compare
4.2800−0.2800 (−6.14%)today
At close: Oct 16, 4:00 PM EDT · May be delayed up to 15 min · CAD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4.5600
Open4.5800
Day range4.28004.6000
52-week range1.080021.5700
Off day high−6.96%
Off 52-week high−80.16%
Volume732.42K
Avg. volume (3M)614.08K
Market cap632.53M
EPS (TTM)-2.08
Forward P/E21.22
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.92
Shares outstanding147.79M
Short interest0.79% of float
Earnings dateOct 8, 2026 (est.)
Analyst target7.7004
Profit margin−17.05%

Against its peers

Compare in full ›
TLRY.TO CGC ACB GLAS TSND.TO TRLV
Market cap 632.53M 320.35M 252.61M 300.63M 249.69M 1.93B
P/E (TTM) — — — — — —
Forward P/E 21.2 -6.0 -36.3 14.2 94.4 18.0
Price/book 0.3 0.6 0.7 3.9 1.8 2.5
Dividend yield — — — — — —
1-year change +94.55% −48.71% −25.14% −61.47% −39.09% +25.28%
Today −6.14% −3.06% −2.68% −14.02% −4.29% −2.82%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All TLRY.TO news ›
MarketBeat·

Tilray Brands (NASDAQ:TLRY) Stock Price Down 5.3% - Time to Sell?

Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report)'s stock price dropped 5.3% during trading on Friday. The company traded as low as $3.03 and last traded at $3.04. Approximately 2,925,854 shares changed hands during mid-day trading, a…

Defense World·Negative

Tilray Brands (TSE:TLRY) Sets New 52-Week Low – Here’s Why

Posted by Defense World Staff on Oct 16th, 2026 Tilray Brands, Inc. (TSE:TLRY – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday. The stock traded as low as C$4.61 and last traded at C$4.64, with a…

@kalkineus·Negative

Why Is Tilray Brands (NASDAQ:TLRY) Swinging on Rescheduling Chatter?

Kalkine Media XTI Aerospace Names Dr. Allan Evans as Chairman and Class I Director Range Resources Reports Preliminary $58.1M Derivative Gain for Q3 2026 Beyond the reform question, cannabis equities operate within a wider market mood that…

markets.businessinsider.com·Positive

TD Cowen Sticks to Their Buy Rating for Tilray (TLRY)

TD Cowen analyst Derek Lessard maintained a Buy rating on Tilray today and set a price target of $4.50. Lessard covers the Consumer Defensive sector, focusing on stocks such as Premium Brands, Saputo Inc., and Maple Leaf Foods. According…

Hanf Magazin·Negative

Bedrocan Insolvency: What It Means for Medical Cannabis Supply

Bedrocan is insolvent. The District Court Groningen opened insolvency proceedings against Bedrocan International B.V., based in Veendam, on October 8, 2026, case number F.18/26/259. This marks the provisional end of the company’s…

From articles in the 4Search news index.

In the news

143mentions in 30 days
50with it in the headline
Mixedsentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.